Get the Stockscreener App
85.98
0.35%
-0.30
After Hours:
86.00
0.02
+0.02%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Merck Co Inc stock is traded at $85.98, with a volume of 12.38M.
It is down -0.35% in the last 24 hours and up +2.44% over the past month.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
See More
Previous Close:
$86.28
Open:
$85.415
24h Volume:
12.38M
Relative Volume:
1.05
Market Cap:
$214.76B
Revenue:
$63.99B
Net Income/Loss:
$19.05B
P/E Ratio:
11.37
EPS:
7.5596
Net Cash Flow:
$14.72B
1W Performance:
-1.73%
1M Performance:
+2.44%
6M Performance:
+0.92%
1Y Performance:
-15.97%
1-Day Range:
$84.56
$86.46
1-Week Range:
$83.30
$88.30
52-Week Range:
$73.31
$105.07
Merck Co Inc Stock (MRK) Company Profile
Name
Merck Co Inc
Sector
Industry
Phone
908-740-4000
Address
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
85.98 | 215.51B | 63.99B | 19.05B | 14.72B | 7.5596 |
|
LLY
Lilly Eli Co
|
862.86 | 757.06B | 59.42B | 18.41B | -50.20M | 20.22 |
|
JNJ
Johnson Johnson
|
188.87 | 455.48B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
218.04 | 403.13B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
123.79 | 235.26B | 54.45B | 14.42B | 17.15B | 7.333 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-25 | Resumed | Citigroup | Neutral |
| Sep-17-25 | Downgrade | Berenberg | Buy → Hold |
| May-14-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-22-25 | Initiated | Cantor Fitzgerald | Neutral |
| Feb-18-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-10-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-08-25 | Downgrade | Truist | Buy → Hold |
| Dec-20-24 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-10-24 | Resumed | BofA Securities | Buy |
| Dec-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-11-24 | Downgrade | Daiwa Securities | Buy → Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Mar-11-24 | Downgrade | Societe Generale | Hold → Sell |
| Jan-04-24 | Upgrade | TD Cowen | Market Perform → Outperform |
| Nov-09-23 | Initiated | Deutsche Bank | Buy |
| Oct-27-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Oct-20-23 | Upgrade | UBS | Neutral → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Hold |
| Apr-13-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Mar-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-06-23 | Initiated | Jefferies | Buy |
| Feb-22-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-04-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| Oct-10-22 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-14-22 | Upgrade | Berenberg | Hold → Buy |
| Jul-06-22 | Upgrade | Daiwa Securities | Neutral → Buy |
| Jun-06-22 | Resumed | SVB Leerink | Outperform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-17-21 | Initiated | Goldman | Buy |
| Dec-16-21 | Initiated | Daiwa Securities | Neutral |
| Dec-13-21 | Downgrade | UBS | Buy → Neutral |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Dec-07-21 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-29-21 | Downgrade | Citigroup | Buy → Neutral |
| Nov-19-21 | Initiated | BMO Capital Markets | Market Perform |
| Nov-01-21 | Upgrade | Argus | Hold → Buy |
| Sep-07-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-27-21 | Resumed | Truist | Buy |
| May-20-21 | Downgrade | Argus | Buy → Hold |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Nov-10-20 | Resumed | Bernstein | Outperform |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Aug-03-20 | Upgrade | Goldman | Neutral → Buy |
| Jun-12-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jan-07-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Aug-16-19 | Initiated | SVB Leerink | Outperform |
| Jul-03-19 | Initiated | Mizuho | Buy |
| May-28-19 | Initiated | Goldman | Neutral |
| May-13-19 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-16-18 | Reiterated | Citigroup | Buy |
| Oct-09-18 | Resumed | Guggenheim | Buy |
| Apr-23-18 | Upgrade | Goldman | Neutral → Buy |
| Apr-17-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-05-18 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-12-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Feb-14-18 | Reiterated | Leerink Partners | Mkt Perform |
| Feb-07-18 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-16-18 | Upgrade | SunTrust | Hold → Buy |
View All
Merck Co Inc Stock (MRK) Latest News
Merck & Co., Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st
Results: Merck & Co., Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - Yahoo Finance
State of Michigan Retirement System Has $58.98 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Nicholas Company Inc. Sells 599,266 Shares of Merck & Co., Inc. $MRK - MarketBeat
Tredje AP fonden Sells 347,631 Shares of Merck & Co., Inc. $MRK - MarketBeat
SS&H Financial Advisors Inc. Increases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Welch & Forbes LLC Sells 5,950 Shares of Merck & Co., Inc. $MRK - MarketBeat
GHP Investment Advisors Inc. Decreases Stake in Merck & Co., Inc. $MRK - MarketBeat
Plato Investment Management Ltd Has $4.98 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Integrity Alliance LLC. Decreases Position in Merck & Co., Inc. $MRK - MarketBeat
Assetmark Inc. Sells 3,278 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Q3 2025 Earnings Call Transcript - Insider Monkey
Merck & Co., Inc. $MRK Position Cut by ANTIPODES PARTNERS Ltd - MarketBeat
Atlas Private Wealth Advisors Trims Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Lifeworks Advisors LLC - MarketBeat
Center for Financial Planning Inc. Sells 3,779 Shares of Merck & Co., Inc. $MRK - MarketBeat
Syverson Strege & Co Acquires Shares of 4,356 Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by AMG National Trust Bank - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by IFG Advisory LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by AlphaQuest LLC - MarketBeat
Morgan Stanley Adjusts Price Target on Merck & Co. to $100 From $98 - MarketScreener
Goldman Sachs Adjusts Price Target on Merck & Co to $92 From $93 - MarketScreener
Companion Animal Health Market to Worth USD 61.74 Billion by 2034, Driven by Rising Pet Ownership and Humanization Trends - GlobeNewswire Inc.
Fisher Funds Management LTD Sells 21,137 Shares of Merck & Co., Inc. $MRK - MarketBeat
Canton Hathaway LLC Lowers Position in Merck & Co., Inc. $MRK - MarketBeat
136,100 Shares in Merck & Co., Inc. $MRK Purchased by Lockheed Martin Investment Management Co. - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Amplius Wealth Advisors LLC - MarketBeat
Premier Path Wealth Partners LLC Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Spire Wealth Management Sells 15,557 Shares of Merck & Co., Inc. $MRK - MarketBeat
Retirement Systems of Alabama Sells 4,775 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Issues Quarterly Earnings Results, Beats Expectations By $0.22 EPS - MarketBeat
Fed. Circ. Explains Rule While Upholding Merck PTAB Loss - Law360
Merck & Co Inc (MRK) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges - Yahoo Finance
Bladder Cancer MarketGlobal and Regional Analysis and Forecast (2025-2035) Featuring Merck & Co., Bristol Myers Squibb, Astellas Pharma, AstraZeneca, and Johnson & Johnson - Yahoo Finance
Merck Ready For Larger Than $15 Billion Deals, Raises Annual Profit OutlookMerck & Co (NYSE:MRK) - Benzinga
Earnings call transcript: Merck Q3 2025 beats forecasts, stock dips - Investing.com
Merck Q3 financial results top estimates, company lowers revenue guidance - Proactive financial news
Merck posts higher third-quarter sales as Keytruda offsets drop in HPV vaccine - Reuters
Merck & Co., Inc. (MRK) Stock: Q3 Profit Jumps 83% as Oncology and Animal Health Drive Growth - CoinCentral
Merck & Co., Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Merck: Wall Street Surprised By Q3 Strength, Keytruda Sales Surge (NYSE:MRK) - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Releases FY 2025 Earnings Guidance - MarketBeat
Ledyard National Bank Has $6.72 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Adell Harriman & Carpenter Inc. Lowers Stake in Merck & Co., Inc. $MRK - MarketBeat
Strs Ohio Has $83.74 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. Updates Earnings Guidance for the Year 2025 - MarketScreener
Merck & Co. Beats Expectations in Q3 2025, Lifts Full-Year Forecast - Tokenist
Heritage Investors Management Corp Acquires 8,073 Shares of Merck & Co., Inc. $MRK - MarketBeat
Amalgamated Bank Has $38.42 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Keytruda Fuels Merck’s Growth Even As Risks Loom - Finimize
Atria Investments Inc Acquires 3,917 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck Co Inc Stock (MRK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):